Accepted Abstracts
International Cancer Study & Therapy Conference
April 04-06, 2016, Baltimore, USA
Combination immunotherapy with tumor-targeting monoclonal antibodies and anti-CD137
Madridge J Cancer Stud Res. 2016
Multifunctional nano- and micro- theranostic platforms for cancer treatment
Madridge J Cancer Stud Res. 2016
Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers
Madridge J Cancer Stud Res. 2016
Efficacy and safety for combination of DCs/CIKs with thoracic radiotherapy for patients with advanced NSCLC
Madridge J Cancer Stud Res. 2016
Hypopharyngeal reconstruction: A comparison of three alternative
Madridge J Cancer Stud Res. 2016
Systemic immune-inflammation index predicts outcome of patients with advanceed hepatocellular carcinoma treated with sorafenib
Madridge J Cancer Stud Res. 2016
Obesity and colon cancer: What is the link?
Madridge J Cancer Stud Res. 2016
Adjuvant therapy in the treatment of gallbladder cancer: A meta-analysis
Madridge J Cancer Stud Res. 2016
In vitro antiproliferative activity of methanolic fraction of Rubus fairholmianus Gard. Root on MCF-7 human breast cancer cells
Madridge J Cancer Stud Res. 2016
Re-irradiation in head and neck malignancies: Challenges and outcomes
Madridge J Cancer Stud Res. 2016
Telomerase sensitizes mammalian cells to aneuploidy-induced transformation by alleviating telomere replication stress
Madridge J Cancer Stud Res. 2016
Cancer stem cells in melanoma: A complex problem
Madridge J Cancer Stud Res. 2016
Metabolic adaptation to anti-angiogenic therapy
Madridge J Cancer Stud Res. 2016
UHRF1 is regulated by miR-9 in colorectal cancer
Madridge J Cancer Stud Res. 2016
Effect of home care service on the sexual satisfaction of patients with gynecologic cancer
Madridge J Cancer Stud Res. 2016
Conmutaxol inhibits tumor metastasis through blocking NOD1/2 mediated NF-κB and MAPKs signaling
Madridge J Cancer Stud Res. 2016
Anti-cancer activity of South African plants and their applications
Madridge J Cancer Stud Res. 2016
Humanized anti-CD47 antibody is a potential effective and safe treatment for pediatric malignant brain tumors
Madridge J Cancer Stud Res. 2016